SRXH — SRx Health Solutions Balance Sheet
0.000.00%
- $6.84m
- $37.88m
- $34.98m
Annual balance sheet for SRx Health Solutions, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 3.93 | 21.7 | 3.17 | 4.46 | 3.07 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4.63 | 6.79 | 6.74 | 4.35 | 7.9 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 17.6 | 43.9 | 27.5 | 16.2 | 15 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.597 | 0.425 | 0.548 | 0.35 | 0.202 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 51.3 | 74.7 | 38.7 | 16.7 | 15.8 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 54.6 | 7.34 | 5.58 | 13.7 | 7.15 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 79.4 | 16.8 | 17.1 | 13.8 | 7.15 |
| Redeemable Preferred Stock | |||||
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -28.1 | 57.9 | 21.5 | 2.98 | 8.65 |
| Total Liabilities & Shareholders' Equity | 51.3 | 74.7 | 38.7 | 16.7 | 15.8 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |